The combined results of nine case–control studies indicated that compared with healthy controls, overall migraine patients had significantly increased S100B levels in peripheral blood (SMD = 0.688, 95% CI: 0.341–1.036, P < 0.001) [7]. This evidence concerns the gene S100B and migraine disorder.